Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
131 studies found for:    Open Studies | "Warfarin"
Show Display Options
Rank Status Study
21 Recruiting Evaluation of Dual Therapy With Dabigatran vs. Triple Therapy With Warfarin in Patients With AF That Undergo a PCI With Stenting (REDUAL-PCI)
Conditions: Atrial Fibrillation;   Percutaneous Coronary Intervention
Interventions: Drug: Dabigatran Etexilate 110mg;   Drug: Warfarin 3mg;   Drug: Aspirin;   Drug: Dabigatran Etexilate 150mg;   Drug: Clopidogrel or Ticagrelor;   Drug: Warfarin 5mg;   Drug: Warfarin 1mg
22 Recruiting Comparison Between Xarelto Versus Warfarin in the Recanalization Rate of Deep Venous Thrombosis in Patients Legs.
Condition: Deep Venous Thrombosis
Interventions: Drug: Rivaroxaban;   Drug: Warfarin
23 Recruiting Apixaban Versus Warfarin in the Evaluation of Progression of Atherosclerotic Calcification and Vulnerable Plaque
Condition: Atrial Fibrillation
Interventions: Drug: apixaban;   Drug: warfarin
24 Recruiting Genotype-guided Warfarin Individualized Treatment
Conditions: Atrial Fibrillation;   Deep Venous Thrombosis
Interventions: Behavioral: Genotype-guided dosing algorithm for warfarin;   Behavioral: Standard initiation dose for warfarin
25 Recruiting A Trial of Genotype-based Warfarin Initiation in Patients With Mechanical Prosthetic Heart Valve
Conditions: Anticoagulation Treatment Overdose;   Heart Valve Diseases
Interventions: Other: Genotype-based Warfarin Initiation model;   Other: clinical factor-based warfarin initiation model
26 Not yet recruiting Model-based Versus Traditional Warfarin Dosing in Children
Condition: Congenital Heart Defects
Interventions: Device: Warfarin Dosing Aid;   Other: Standard Practice
27 Not yet recruiting Evaluate the Pharmacokinetics of Warfarin When Coadministered With PEX168 in Healthy Adult Subjects
Condition: Healthy
Interventions: Drug: PEX168;   Drug: Warfarin
28 Unknown  Warfarin Versus Aspirin in Patients With Atrial Fibrillation and Chronic Kidney Disease
Conditions: Atrial Fibrillation;   Chronic Kidney Disease
Interventions: Drug: warfarin;   Drug: aspirin
29 Not yet recruiting Hemorrhage Following Small Polyp Resection in the Colon in Anticoagulated Patients
Conditions: Post Polypectomy Bleeding in Anticoagulated Patients;   Gastrointestinal Hemorrhage
Interventions: Drug: Warfarin;   Drug: LMW Heparin
30 Recruiting Short Term Warfarin Therapy for Radiofrequency Catheter Ablation of Atrial Fibrillation
Condition: Atrial Fibrillation
Intervention: Drug: warfarin
31 Recruiting Rivaroxaban Versus Warfarin in the Evaluation of Progression of Coronary Calcium
Condition: Atherosclerosis
Interventions: Drug: rivaroxaban;   Drug: Warfarin
32 Recruiting Statin Use in Patients With Acute VTE
Condition: Venous Thromboembolism
Interventions: Drug: Atorvastatin;   Drug: Warfarin
33 Recruiting EdoxabaN or Warfarin Therapy In Cardiovascular Implantable Electrical Device Procedures in Patients With Non-Valvular Atrial Fibrillation
Condition: Atrial Fibrillation
Interventions: Drug: Edoxaban;   Drug: Warfarin
34 Recruiting Comparison Between Thoracoscopic Left Atrial Appendage Excision and Warfarin for the Secondary Prevention of Stroke in Patients With AF
Conditions: Atrial Fibrillation;   Stroke;   Systemic Embolism
Interventions: Procedure: Thoracoscopic Left Atrial Appendage Excision;   Drug: Warfarin
35 Recruiting Pharmacokinetic Drug-Drug Interaction Study of Rucaparib
Condition: Neoplasms
Interventions: Drug: Caffeine;   Drug: Warfarin;   Drug: Omeprazole;   Drug: Midazolam;   Drug: digoxin;   Drug: Vitamin K;   Drug: Rucaparib
36 Recruiting The Secondary Prevention of Nonvalvular Atrial Fibrillation Patients With an Initial Cardioembolic Stroke
Conditions: Cardioembolic Stroke;   Atrial Fibrillation
Interventions: Drug: aspirin plus hirudin;   Drug: Warfarin
37 Recruiting Registry for Estimation of Warfarin and Rivaroxaban in Atrial Fibrillation Patients With Coronary Stent Implantation
Conditions: Coronary Artery Disease;   Atrial Fibrillation;   Stroke;   Fetal Blood Loss
Intervention: Drug: Warfarin or Rivaroxaban
38 Unknown  The Association of Warfarin Dosage and Plasma Enantiomer Concentration With the Gene Polymorphisms of CYP and VKOR
Condition: Deep Venous Thromboembolism
Intervention: Drug: warfarin
39 Unknown  VKORC1 and CYP2C9 Gene Polymorphisms and Warfarin Management
Conditions: Atrial Fibrillation;   Cardiac Thrombus;   Deep Vein Thrombosis;   Pulmonary Embolism;   Heart Valve Replacement (Mechanical or Biological With AF);   Cardiomyopathy (Ischemic or Dilated);   Peripheral Vascular Disease
Intervention: Drug: Warfarin dose titration
40 Not yet recruiting A Clinical Trial Comparing Efficacy and Safety of Dabigatran Etexilate With Warfarin in Patients With Cerebral Venous and Dural Sinus Thrombosis (RE-SPECT CVT)
Condition: Thromboembolism
Interventions: Drug: Dabigatran etexilate;   Drug: Warfarin

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years